09:08 AM EST, 11/12/2024 (MT Newswires) -- Disc Medicine ( IRON ) reported a Q3 loss Tuesday of $0.89 per share, wider than a loss of $0.58 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.99.

As expected, no revenue for the quarter ended Sept. 30 was reported.

As of Sept. 30, the company had $487.4 million in cash, cash equivalents and marketable securities, which it expects will fund its operations into 2027.